InsiderTrades

Form 4 for LIF Life360, Inc.

Accepted 2026-09-23 16:48:06 ET · period of report 2026-09-21 · accession 0001581760-26-000165 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-09-23 16:48 2026-09-21 LIF Haro Alex Dir M - OptEx $2.53 +50.0K 1.06M +5% +$126.5K
DMT 2026-09-23 16:48 2026-09-21 LIF Haro Alex Dir S - Sale+OE $40.88 -50.0K 1.01M -5% -$2.04M
DT 2026-09-23 16:48 2026-09-21 LIF Haro Alex Dir M - OptEx $0.00 -50.0K 195.6K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common stock 2026-09-21 M A 50,000 $2.53 1,060,303 D — — (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F2) Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
2 Common Common stock 2026-09-21 S D 31,275 $40.72 1,029,028 D — — (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.02, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3. (F2) Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3 Common Common stock 2026-09-21 S D 18,725 $41.16 1,010,303 D — — (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.047 to $41.340, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4. (F2) Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
4 Derivative Stock Option (right to buy) 2026-09-21 M D 50,000 $0.00 195,565 D $2.53 · — to 2028-07-16 50,000 Common stock (F1) The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. (F5) The stock option is fully vested and exercisable.